Global X Management Co. LLC has recently announced that it has increased stake in MyMD Pharmaceuticals Inc (NASDAQ:MYMD) by 4.31%. After grabbing 0.93 million shares, the institutional investor is now in possession of 38615.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.84% having worth around $0.26 million. Moreover, Geode Capital Management LLC increased its share by 8979.0 to have a control over 0.29 million shares. And Praetorian Wealth Management, Inc raised its holdings to 0.17 million shares by acquiring 0.2 million shares or 0.39% of the stake.
MyMD Pharmaceuticals Inc (MYMD) concluded trading on 12/27/23 at a closing price of $0.34, with 5.93 million shares of worth about $2.02 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -78.25% during that period and on Wednesday the price saw a gain of about 40.93%. Currently the company’s common shares owned by public are about 50.90M shares, out of which, 43.49M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Global X Cannabis ETF, Vanguard Total Stock Market ETF, and Vanguard Extended Market Index Fu are the top 3 mutual funds which are holding stakes in MyMD Pharmaceuticals Inc Global X Cannabis ETF is currently holding 3.17 million shares of worth totaling $0.89 million. The company recently came buying 0.0 shares which brought its stake up to 6.22% of the company’s outstanding shares. Vanguard Extended Market Index Fu, after buying 0.41 million shares, have now control over 0.81% of the stake in the company. It holds 0.0 shares of worth $0.11 million.
MyMD Pharmaceuticals Inc (NASDAQ: MYMD) started trading at $0.23, below -$0.01 from concluding price of the previous day. However, the stock later moved at a day high price of 0.3555, or with a gain of 40.93%. Stock saw a price change of 52.13% in past 5 days and over the past one month there was a price change of 10.20%. Year-to-date (YTD), MYMD shares are showing a performance of -70.87% which decreased to -67.94% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.20 but also hit the highest price of $2.98 during that period. The average intraday trading volume for MyMD Pharmaceuticals Inc shares is 777.46K. The stock is currently trading 31.49% above its 20-day simple moving average (SMA20), while that difference is up 3.71% for SMA50 and it goes to -69.43% lower than SMA200.
Global X Management Co. LLC acquired 0.93 million shares of MyMD Pharmaceuticals Inc having value of about $0.26 million. Data submitted at the U.S SEC by Global X Management Co. LLC revealed that the firm now holds 38615.0 shares in the company valued at close to $13129.1, or have control over 4.31% stake in the company. MyMD Pharmaceuticals Inc (NASDAQ: MYMD) currently have 50.90M outstanding shares and institutions hold larger chunk of about 8.51% of that. Holding of mutual funds in the company is about 1.19% while other institutional holders and individual stake holders have control over 10.16% and -1.65% of the stake respectively.
The stock has a current market capitalization of $17.05M and its 3Y-monthly beta is at 2.33. It has posted earnings per share of -$0.19 in the same period. It has Quick Ratio of 1.71 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MYMD, volatility over the week remained 17.16% while standing at 13.04% over the month.
Analysts are in expectations that MyMD Pharmaceuticals Inc (MYMD) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is $0 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same.
Analysts at 1 brokerage firms have issued recommendations for the MyMD Pharmaceuticals Inc (MYMD)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
